The Netherlands: Lunit chooses Amsterdam as base to expedite European expansion

Lunit, a global provider of AI-powered cancer solutions, has decided to establish a new subsidiary, Lunit Europe Holding, to expedite its business development across the European Union and the European Free Trade Association (EFTA). Lunit will hold 100% of the subsidiary’s stake. Previously managed through its branch office, the establishment of Lunit Europe Holdings will…

You must be a HMI Subscriber to view this content.

Subscribe Now »